Total Funding
48
19
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
391246
Mx Biodevices develops and commercializes an injectable nanoscaffold for the treatment of diabetic foot ulcers and other chronic wounds.
Marilyn Thompson: Co-founder
About the Company
MxBiodevices was founded in August 2009 specifically to commercialize an injectable nano scaffold, E-Matrix, for the treatment of diabetic foot ulcers (DFU’s) and other chronic wounds. The company's founders were instrumental in E-Matrix development over the last 12 plus years, which led to 6 commercially successful E-Matrix products in
orthopedics and spine.
In February 2012 MxBiodevices obtained the exclusive license for E-Matrix treatment of all chronic wounds including DFU’s, decubitus ulcers, venous stasis ulcers, and surgical adhesions. The company has completed two FDA IDE clinical studies of E-Matrix treatment of DFU’s.
Women Founded
